China has recently launched a wave of “vaccine diplomacy” with the high-profile use of the inactivated vaccine “CoronaVac” produced by Sinovac, but only 50% of the vaccine is effective or not by chance. In Indonesia, it was recently reported that a health care worker was killed after receiving the Corona Vaccine.
The Malaysian Chinese media “China Daily” reported on the 24th that a 33-year-old female nurse at Ngudi Waluyo District General Hospital in Beirut, East Java, died nine days after being vaccinated with the Coxin vaccine and being diagnosed with Wuhan pneumonia (new coronavirus disease, COVID-19).
According to the report, Ani was administered the Coxin vaccine on January 28. Before the second shot, she complained of fever, breathing difficulties and coughing. She was admitted to the hospital on Feb. 5, admitted to an intensive care unit on Feb. 6 and died on Feb. 14.
The Indonesian Ministry of Health did not explain much about the safety of the Coxin vaccine, but stressed that the vaccine can only trigger a partial response from the body’s immune system after the first dose is administered, and that if the body’s immune system is to react completely to the virus, it must wait 14 to 28 days for the second dose to trigger a complete response from the immune system and immunity to the virus.
However, new data released by Brazil last month showed that the Kexing vaccine is only 50.4 percent effective. The advantage of this inactivated vaccine, which is manufactured in the traditional way, is that it can be stored at conventional refrigerator temperatures (2 to 8 degrees), making it easier to transport and store in rudimentary areas, allowing China to use it for “vaccine diplomacy” to poor countries, but The fact that it does not require ultra-low temperature storage has also allowed counterfeit Kexin vaccines to spread around China and even to overseas markets.
Hong Kong authorities are scheduled to administer the Coxin vaccine for free to specific populations starting Feb. 26, but the Joint Scientific Committee has warned that the Coxin vaccine has limited effectiveness and the highest side effects. The committee also pointed out in a government bulletin that the results of Phase III clinical tests of the Coxin vaccine have not been published in peer-reviewed academic journals.
The lack of transparency has been a major reason for criticism of China’s Home-grown vaccines, and the fact that China’s state-owned vaccine companies have been implicated in expired vaccines, adverse reactions to vaccines, and bribery of officials in the past, and that no high-ranking Communist Party officials have taken the lead in vaccination, has led many to worry about the safety and effectiveness of vaccines.
Recent Comments